U.S. Trade Distributors Stock News

Zions Bancorporation National Association (NasdaqGS:ZION) announced a 6.7% increase in its quarterly common dividend. The company also authorized a new US$75 million share repurchase program scheduled for the third quarter of 2026. Zions Bancorporation National Association focuses on regional banking services, including lending, deposit gathering, and treasury offerings for businesses and consumers. Dividend decisions and buyback authorizations are closely watched in the banking sector,...

Arcus Biosciences and Summit Therapeutics previously announced a clinical trial collaboration to test Arcus’s oral HIF-2a inhibitor casdatifan with Summit’s PD-1/VEGF bispecific antibody ivonescimab in metastatic clear cell renal cell carcinoma, adding a new combination cohort to Arcus’s ongoing ARC-20 platform study. An interesting aspect of this collaboration is that both companies retain full rights to their own drugs while sharing study costs, potentially expanding each firm’s kidney...

Recent commentary around W.W. Grainger (GWW) has focused on expectations for year over year growth in sales and earnings per share ahead of its upcoming quarterly report, giving investors fresh context for the stock. See our latest analysis for W.W. Grainger. Against this backdrop, W.W. Grainger’s share price has climbed 20.34% over the past 90 days and 37.70% year to date, while its 1 year total shareholder return of 49.53% reflects recent performance. If Grainger’s move has you thinking...

Since late July 2026, several law firms, including Kaplan Fox, Pomerantz, and Rosen Law Firm, have launched securities class action lawsuits against GPGI, Inc. over alleged misleading statements tied to its Husky Technologies Limited acquisition and subsequent earnings and guidance updates. These legal actions focus on whether investors were misinformed about the valuation and expected benefits of the Husky deal, raising fresh questions about GPGI’s disclosure practices and...

Host Hotels & Resorts has delivered a 97.7% total return over the past five years, yet valuation checks suggest the stock may still trade below an estimate of its intrinsic value. The key question is how much weight to give a Discounted Cash Flow (DCF) estimate that points to upside versus a broader set of checks that only signal a mixed value picture. A 97.7% return over five years puts Host Hotels & Resorts firmly in the group of stocks that have already rewarded patient shareholders,...

JBG SMITH Properties has seen its share price fall 43.7% over the past five years, yet current valuation work suggests the stock may now be trading below its estimated intrinsic value based on a Discounted Cash Flow (DCF) model and traditional market multiples. The share price decline of 43.7% over five years raises the question of whether sentiment has become more pessimistic than the underlying fundamentals justify. Future cash generation from JBG SMITH Properties' property portfolio can...

The bond market just sent a loud message. The Federal Reserve under Kevin Warsh kept rates on hold, yet long term Treasury yields surged to levels last seen in 2007 while shorter yields eased. At the same time, the Fed’s limited guidance has left investors guessing about inflation and future volatility. For banks and insurers with solid balance sheets, that mix of higher long term rates and shaken Fed credibility can create both openings and traps. This article walks through three financially...

Bank First stock has delivered a 137.8% return over the past 5 years, yet current valuation checks and the latest intrinsic value estimate suggest the shares may now be trading at a premium rather than offering clear value. A 137.8% share price gain over 5 years points to a stock that has already rewarded long term holders, which raises the bar for future returns from today’s price. Recent earnings growth and a higher dividend can support investors’ expectations, while any disappointment in...

AI in healthcare sits at the crossroads of powerful trends that matter for investors, from aging populations and rising treatment costs to central banks wrestling with inflation and bond yields. While higher yields and shifting policy expectations keep pressure on parts of the market, the Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, treatment decisions, hospital efficiency and remote care. These tools aim to cut waste, support clinicians...

The new 50% tariff on certain Canadian imports is shaking up cross border trade, and that can ripple through everything from farm exports to grocery shelves. Missouri and other Canada reliant states sit right in the path of this policy change, while sectors like U.S. dairy could see a different set of pressures and openings if trade barriers shift. For investors, the key question is which companies might benefit and which face higher uncertainty. This article looks at three U.S. dairy...

Thermo Fisher Scientific showcased multiple new diagnostic solutions at the 2026 Association for Diagnostics & Laboratory Medicine Annual Meeting. The EXENT Solution secured FDA 510(k) clearance for use in multiple myeloma diagnosis. The EliA CTD 13 Screen gained FDA clearance for systemic autoimmune connective tissue diseases. The company also highlighted previously cleared assays for rapid oncology and preeclampsia testing and previewed new digital tools for lab workflow efficiency. For...

Ares Management (ARES) just reported a busy second quarter, combining record fundraising and higher revenue with fresh dividend declarations for both its common and preferred stock. Investors now have new numbers and payout details to weigh. See our latest analysis for Ares Management. Ares Management’s latest earnings and dividend news landed alongside a sharp 12.73% 1 month share price return and a 7.64% 3 month share price return, yet the stock is still down 22.99% on a year to date share...

Kiniksa Pharmaceuticals International (KNSA) drew fresh attention after it raised its 2026 net product revenue guidance to US$980 million to US$995 million, following second quarter results and a company pipeline update. See our latest analysis for Kiniksa Pharmaceuticals International. Kiniksa Pharmaceuticals International’s recent guidance hike and strong second quarter results have come after a powerful run, with a year to date share price return of 76.98% and a 1 year total shareholder...

In late July 2026, Fiverr International reported that second-quarter revenue fell to US$97.78 million from US$108.65 million a year earlier, even as net income increased to US$4.47 million and diluted EPS rose to US$0.12. At the same time, the company cut its third-quarter and full-year 2026 revenue guidance, citing AI-related demand and traffic headwinds and weaker activity in categories most exposed to automation, even though profitability improved over the first half of the year. Next,...

In late July 2026, Franklin Resources, Inc. reported third‑quarter results showing revenue of US$2.36 billion and net income of US$171.5 million, alongside a US$33.0 million impairment of intangible assets and confirmation of an ongoing share repurchase program totaling US$7.17 billion since 2013. The company also recorded record US$1.80 trillion in assets under management with US$18.4 billion in long-term net inflows and announced a corporate name change to Franklin Templeton, Inc.,...

Carlyle Group (CG) is back in focus after Carlyle Credit Solutions Inc., its non-traded business development company, reported investor redemption requests of about 3.6% of outstanding shares, below the fund’s cap and below the prior quarter. See our latest analysis for Carlyle Group. Set against this steadier picture at Carlyle Credit Solutions, Carlyle Group’s stock has seen a 1-month share price return of 8.72% even as the year to date share price return is down 24.38%. The 3-year total...

Trump’s new 50% tariff on selected Canadian imports has put a fresh spotlight on Missouri stocks that lean on cross-border trade. Higher input costs, possible retaliation from Canada, and pressure on exporters now sit at the center of the story for several Missouri linked companies. This article looks at three stocks from the Missouri Cross-Border Trade Exposure Stocks Amid Canada Tariffs screener that appear especially exposed to this news. All three are assessed as potential candidates to...

Citizens Financial Group stock has delivered a very strong 158.7% return over the past three years, yet the current checks send a mixed message, with an intrinsic value estimate from the Excess Returns model indicating the shares may still trade below that estimate while market based multiples look roughly in line. The 158.7% three year return means anyone who stayed invested in Citizens Financial Group through that period has seen the stock multiply in value. This raises the bar for any new...

Investors in Axogen, Inc. ( NASDAQ:AXGN ) had a good week, as its shares rose 6.9% to close at US$42.21 following the...

Shareholders might have noticed that Reynolds Consumer Products Inc. ( NASDAQ:REYN ) filed its second-quarter result...

There's been a major selloff in Orion Group Holdings, Inc. ( NYSE:ORN ) shares in the week since it released its...

Shareholders will be ecstatic, with their stake up 39% over the past week following Pulmonx Corporation 's...

Shareholders of Sprouts Farmers Market, Inc. ( NASDAQ:SFM ) will be pleased this week, given that the stock price is up...

Oceaneering International earnings and buyback catch investor attention Oceaneering International (OII) drew fresh attention after reporting second quarter 2026 results that showed higher sales and net income, alongside an update on its long running share repurchase program. For the second quarter ended June 30, 2026, the company reported sales of US$768.18 million compared with US$698.16 million a year earlier. Net income was US$65.02 million compared with US$54.44 million, with diluted...